Who are Crescent Manufacturing?
Established in 2016 and located in Park Royal, London, Crescent Manufacturing is an MHRA-licensed pharmaceutical manufacturing facility specialising in the production of beta-lactam antibiotics, liquid medicines, creams and gels. As part of the Crescent Pharmaceutical Group's integrated UK manufacturing network, the site plays a key role in strengthening domestic pharmaceutical manufacturing capacity and ensuring the reliable supply of high-quality medicines to the NHS, pharmacies, wholesalers and international markets.
The facility comprises two dedicated GMP manufacturing units, purpose-built to support specialist production requirements. Our liquid manufacturing facility extends across approximately 30,000 square feet, complemented by a dedicated 10,000 square foot beta-lactam antibiotics facility. Located within one of London's principal industrial and logistics hubs, the site benefits from excellent transport links, supporting efficient distribution throughout the UK.
Operating under MHRA-approved Good Manufacturing Practice (GMP) licences, Crescent Manufacturing maintains the highest standards of quality, compliance and operational excellence.
The site is supported by an MHRA-approved warehousing facility with capacity for approximately 3,900 pallets, enabling integrated manufacturing, storage and distribution from a single UK location. This infrastructure enhances supply chain resilience, supports business continuity and provides the flexibility to meet changing market demand while maintaining the highest levels of product quality and patient safety.
Our manufacturing capabilities
Our liquid and semi-solid manufacturing infrastructure supports reliable, efficient production across a range of pharmaceutical dosage forms. Crescent Manufacturing combines established manufacturing capability with dedicated production equipment and processes designed to support consistent product supply.
Crescent Manufacturing combines established pharmaceutical manufacturing capability with a strong focus on quality, operational responsiveness and continuity of supply. Our UK manufacturing infrastructure enables us to respond to changing market requirements and, where needed, support the NHS and wider UK healthcare system during periods of urgent demand, including increased requirements for antibiotic medicines.Continued investment in our facilities, capabilities and product portfolio strengthens our ability to support the reliable supply of medicines to healthcare providers across the UK.
Over 10,000,000 bottle capacity, showcasing our ability to meet large-scale production requirements.
3 x 5000L process vessels, ensuring optimal handling and processing of our products.
3 x 1500L process vessels, facilitating efficient and precise manufacturing operations.
4 x liquid filling and packing lines, allowing for swift and accurate packaging of our liquid-based products.
1 x Antibiotic filling and packing line, dedicated to ensuring the safe and precise packaging of our essential Antibiotic products.
2 x serialisation machines, emphasising our commitment to product traceability and compliance.
1 x Powder blending machine, enabling us to create custom formulations with meticulous precision.
Why Crescent Manufacturing?
Liquid Site
The liquids manufacturing site is approximately 30,000 square feet, with over 10,000,000 bottle capacity
Antibiotics Site
Antibiotics site is approximately 10,000 square feet, with over 2,000,000 bottle capacity
Approved Facilities
MHRA approved UK based manufacturing site
Warehouse space
Extensive London based warehouse space with in excess of 2.5k pallet capacity.